The virtual conference held by the American Heart Association (AHA) in November has left us with new data from a broad range of late-breaking trials.

In the area of interventional cardiology, M. Chadi Alraies, MD, FACC, lists five standouts with implications for our clinical practice, including ARREST, RIVER, ALPHEUS and more. Read more.

Follow Cardiology on Twitter using #CardiologyMag and get the full issue here.